百晓学者学者目录

朱波

副教授、博士生导师，南京大学

精选作品

期刊论文

2025

Green governance and value relevance of earnings

Bo Zhu, Shaoqian Wu

International Review Of Financial Analysis，Vol. 102

DOI

2025

Do climate risks matter for intersectoral systemic risk spillovers? Evidence from China

Xin Hu, Bo Zhu

Finance Research Letters，Vol. 75

DOI

2023

Caspase-8 contributes to an immuno-hot microenvironment by promoting phagocytosis via an ecto-calreticulin-dependent mechanism

Z. Gong, Q. Jia, Jin-Ming Guo, Chongyi Li, Shouxia Xu, Zheng Jin, Han Chu, Y. Wan, Bo Zhu, Yi Zhou

Experimental Hematology & Oncology

DOI

2023

Tumor-specific memory CD8+ T cells are strictly resident in draining lymph nodes during tumorigenesis

Qiao-Yi Liu, Ling Ran, Zhengliang Yue, Xing-Xing Su, Lisha Wang, Shuqiong Wen, Shun Lei, Xiaofan Yang, Yan Zhang, Jianjun Hu, Jian-Fang Tang, Zhi-Rong Li, Li Hu, Bo Zhu, Li-Fan Xu, L. Ye, Qi-Zhao Huang

Cellular & Molecular Immunology

DOI

2023

Chromothripsis is correlated with reduced cytotoxic immune infiltration and diminished responsiveness to checkpoint blockade immunotherapy

Han Chu, Zheng Jin, Jia-Nan Cheng, Q. Jia, Bo Zhu, Haoyang Cai

Theranostics

DOI

2023

EBV-upregulated B7-H3 inhibits NK cell-mediated antitumor function and contributes to nasopharyngeal carcinoma progression.

Haiwen Chen, Xiaobing Duan, Xiao-Hong Deng, Ying Huang, Xiang Zhou, Shanshan Zhang, Xiao Zhang, Pingjuan Liu, Chao-Pin Yang, Guojun Liu, Qinqin Ren, Yan Xiong, Bo Zhu, Jie-Xia Zhang, T. Xiang

Cancer immunology research

DOI

2023

CD200+ cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti–PD-1/PD-L1 therapy

Xinxin Wang, H. Zha, Wei Wu, T. Yuan, Shuanglong Xie, Zheng Jin, H. Long, Fei Yang, Zhongyu Wang, Anmei Zhang, Jianbao Gao, Ying Jiang, Lu-Jing Wang, Chun-Yan Hu, Y. Wan, Qi-Jing Li, A. Symonds, Q. Jia, Bo Zhu

Science Translational Medicine

DOI

2023

Author Correction: Tumor-specific memory CD8+ T cells are strictly resident in draining lymph nodes during tumorigenesis

Qiao-Yi Liu, Ling Ran, Zhengliang Yue, Xing-Xing Su, Lisha Wang, Shuqiong Wen, Shun Lei, Xiaofan Yang, Yan Zhang, Jianjun Hu, Jian-Fang Tang, Zhi-Rong Li, Li Hu, Bo Zhu, Li-Fan Xu, L. Ye, Qi-Zhao Huang

Cellular & Molecular Immunology

DOI

2022

Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy.

H. Long, Q. Jia, Liuyang Wang, W. Fang, Zhongyu Wang, Tao Jiang, Fei Zhou, Zheng Jin, Jia-Ni Huang, Li Zhou, Chunyan Hu, Xinxin Wang, Jin Zhang, Yujie Ba, Yujie Gong, Xiang-Hua Zeng, D. Zeng, Xing-Xing Su, Peter B. Alexander, Li Wang, Limei Wang, Y. Wan, Xiao-Fan Wang, Li Zhang, Qi-Jing Li, Bo Zhu

Cancer Cell

DOI

2022

Differential expression of inhibitory receptor NKG2A distinguishes disease‐specific exhausted CD8+ T cells

Xiang-Yu Chen, Yao Lin, S. Yue, Yang Yang, Xinxin Wang, Z. Pan, Xiaofan Yang, Lei-Qiong Gao, Jing Zhou, Zhi-Rong Li, Li Hu, Jian-Fang Tang, Qing Wu, Yi-Fei Wang, Qin Tian, Ya-Xing Hao, Li-Fan Xu, Bo Zhu, Qi-Zhao Huang, L. Ye

MedComm

DOI

2022

High-throughput single-сell sequencing in cancer research

Q. Jia, Han Chu, Zheng Jin, H. Long, Bo Zhu

Signal Transduction and Targeted Therapy

DOI

2022

Modulating Tumor Physical Microenvironment for Fueling CAR-T Cell Therapy.

Zhong Luo, Xuemei Yao, Meng-Huan Li, De-xin Fang, Yang Fei, Zhuo Cheng, Ying-Ying Xu, Bo Zhu

Advanced Drug Delivery Reviews

DOI

2022

Type I interferon-mediated tumor immunity and its role in immunotherapy

Renren Yu, Bo Zhu, Degao Chen

Cellular and Molecular Life Sciences

DOI

2022

Neoantigens in precision cancer immunotherapy: from identification to clinical applications

Qiao-Ling Zhang, Q. Jia, Jing Zhang, Bo Zhu

Chinese Medical Journal

DOI

2022

Heterogeneity of the tumor immune microenvironment and its clinical relevance

Q. Jia, Aoyun Wang, Yixiao Yuan, Bo Zhu, H. Long

Experimental Hematology & Oncology

DOI

2021

Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma

Q. Jia, Diyuan Qin, Feng He, Qichao Xie, Z. Ying, Ya-Jing Zhang, Yu-Qin Song, Jia-Nan Cheng, Xuejiao Zuo, Lu-Xiang Xu, Hong-Liang Fang, Chunyan Hu, Li-Na Peng, Tao Jin, Zi-Xiao Shi, Peter B. Alexander, Yong-Sheng Wang, Yarong Liu, Weidong Han, Jun Zhu, Pin Wang, Qi-Jing Li, Bo Zhu

Theranostics

DOI

2021

Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression

Jia-Nan Cheng, Yifang Yuan, Bo Zhu, Q. Jia

Frontiers in Cell and Developmental Biology

DOI

2021

Titin mutation in circulatory tumor DNA is associated with efficacy to immune checkpoint blockade in advanced non-small cell lung cancer

C. Su, Xinxin Wang, Juan Zhou, Jing‐ya Zhao, Fei Zhou, Guo-Dong Zhao, Xiao-Hong Xu, X. Zou, Bo Zhu, Q. Jia

Translational Lung Cancer Research

DOI

2021

Non-canonical PD-1 signaling in cancer and its potential implications in clinic

H. Zha, Ying Jiang, Xi Wang, Jin Shang, Ning Wang, Lei Yu, Wei Zhao, Zhi-Hua Li, Juan An, Xiaochun Zhang, Huo-ming Chen, Bo Zhu, Zhao-Xia Li

Journal for ImmunoTherapy of Cancer

DOI

2021

ENPEP as a potential predictor of immune checkpoint inhibitor efficacy

Aoyun Wang, Han Chu, Zheng Jin, Z. Gong, Q. Jia, Bo Zhu

Cancer Medicine

DOI

2021

Clinical characteristics of primary hepatic angiosarcoma outcomes: a SEER database analysis

D. Zeng, Xiang-Hua Zeng, Jun Duan, Dian-gang Chen, Bo Zhu

Translational Cancer Research

DOI

2021

Embryonic Origin and Subclonal Evolution of Tumor-Associated Macrophages Imply Preventive Care for Cancer

Xiao-Mei Zhang, Degao Chen, S. Li, Bo Zhu, Zhong-Jun Li

Cells

DOI

2021

Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma

Pu Zhou, Dian-gang Chen, Bo Zhu, Wei Chen, Qichao Xie, Ya-Li Wang, Qiu-lin Tan, Bi-Bo Yuan, Xuejiao Zuo, Chang-Ling Huang, Hongfan Zhu, Guanghui Li

Frontiers in Immunology

DOI

2021

Radiation-induced eosinophils improve cytotoxic T lymphocyte recruitment and response to immunotherapy

Jia-Nan Cheng, Wen Luo, Chengdu Sun, Zheng Jin, Xiang-Hua Zeng, Peter B. Alexander, Z. Gong, Xin Xia, Xiao-Fan Ding, Shouxia Xu, P. Zou, Y. Wan, Q. Jia, Qi-Jing Li, Bo Zhu

Science Advances

DOI

2021

Impact of Dissected Lymph Node Count on PD-1 Inhibitors Efficacy in Postoperative Recurred NSCLC: A Multi-Institutional Retrospective Study

C. Su, H. Deng, Juan Zhou, Hualin Chen, Xiuyu Cai, R. Zhong, Feng Li, B. Cheng, Cai-Chen Li, Q. Jia, Cai-Cun Zhou, Jian-Xing He, R. Peterson, G. Rocco, A. Brunelli, C. Ng, T. D'Amico, W. Liang, Bo Zhu

Social Science Research Network

DOI

2021

Mutational burden and chromosomal aneuploidy synergistically predict survival from radiotherapy in non-small cell lung cancer

Q. Jia, Q. Chu, Anmei Zhang, Jing Yu, Fang-Fang Liu, Kai-Yu Qian, Yu Xiao, Xue Wang, Ying Yang, Yi Zhao, Ji He, Guanghui Li, Y. Wan, C. Xie, Bo Zhu

Communications Biology

DOI

2021

Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages

Degao Chen, Xiao-Mei Zhang, Zhong-Jun Li, Bo Zhu

Theranostics

DOI

2021

Fusion of Invasive Tumor Cells with Infiltrating Macrophages Fuels Epithelial-Mesenchymal Transition and Adaptive Immune Evasion

Xiao-feng Han, Bo Zhu, Xue-Mei Zhang, Jing Luo, Hui Chen, Yun-ping Hu, Faith Liu, Christine Brown, Amy Burnside, Guohui Fu, Fa-Xue Zhao, Hong-Zhuan Chen, Denise Oh, L. Schwartz, Yingbin Liu, R. Shao

DOI

2021

Programmed Cell Death Protein Ligand 2 Is a Potential Biomarker That Predicts the Efficacy of Immunotherapy

Aoyun Wang, Han Chu, Zheng Jin, Q. Jia, Bo Zhu

Disease Markers

DOI

2020

Neoantigen Tracking: Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer (Adv. Sci. 9/2020)

Q. Jia, Luting Chiu, Shuang-Xiu Wu, J. Bai, Li-Na Peng, Linpeng Zheng, Rui Zang, Xue-Qin Li, Bi-Bo Yuan, Yi-Xing Gao, Dingyong Wu, Xiao-Hong Li, Lin Wu, Jian-Guo Sun, Ji He, Bruce W. S. Robinson, Bo Zhu

Advancement of science

DOI

2020

The mechanisms of pathological extramedullary hematopoiesis in diseases

Xin-Xin Yang, Degao Chen, H. Long, Bo Zhu

Cellular and Molecular Life Sciences

DOI

2020

Immune subtype of mismatch repair deficient colorectal carcinoma.

N. He, Q. Jia, Ge Jin, Bo Zhu

DOI

2020

Transformation to Lung Adenocarcinoma From Complete Remission-Experienced SCLC.

Zhongyu Wang, Q. Jia, Xuefeng Tang, Lvjun Yan, Bo Zhu

Journal of Thoracic Oncology

DOI

2020

Antitumor effects of targeting myeloid-derived suppressive cells

D. Zeng, H. Long, Bo Zhu

Translational Cancer Research

DOI

2020

Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer

Q. Jia, Luting Chiu, Shuang-Xiu Wu, J. Bai, Li-Na Peng, Linpeng Zheng, Rui Zang, Xue-Qin Li, Bi-Bo Yuan, Yi-Xing Gao, Dingyong Wu, Xiao-Hong Li, Lin Wu, Jian-Guo Sun, Ji He, Bruce W. S. Robinson, Bo Zhu

Advancement of science

DOI

2020

A pooled analysis of primary hepatic angiosarcoma.

D. Zeng, Jia-Nan Cheng, Z. Gong, Jianghong Chen, H. Long, Bo Zhu

Japanese Journal of Clinical Oncology

DOI

2020

Effect of Comorbidity on Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD1 Immunotherapy

Xiang-Hua Zeng, Shi-Cong Zhu, Cheng Xu, Zhongyu Wang, Xing-Xing Su, D. Zeng, H. Long, Bo Zhu

Medical Science Monitor

DOI

2020

Gene expression profiling identified TP53MutPIK3CAWild as a potential biomarker for patients with triple-negative breast cancer treated with immune checkpoint inhibitors

Jia-Nan Cheng, Xiao-Fan Ding, Shouxia Xu, Bo Zhu, Q. Jia

Oncology Letters

DOI

2020

C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts

Chi Shu, H. Zha, H. Long, Xinxin Wang, Fei Yang, Jianbao Gao, Chunyan Hu, Li Zhou, Bo Guo, Bo Zhu

Journal of experimental & clinical cancer research : CR

DOI

2019

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

Sha Zhao, S. Ren, T. Jiang, Bo Zhu, Xue-Fei Li, Chao Zhao, Yijun Jia, Jinpeng Shi, Limin Zhang, Xiao-Zhen Liu, M. Qiao, Xiaoxia Chen, C. Su, Hui Yu, Cai-Cun Zhou, Jun Zhang, D. Camidge, Fred R. Hirsch

Cancer immunology research

DOI

2019

EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells.

Shuo Huang, Zhongyu Wang, Jie Zhou, Jia-Ni Huang, Li Zhou, Jing Luo, Y. Wan, H. Long, Bo Zhu

Cancer Research

DOI

2019

EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells.

Yuetao Zhao, Xin-Xin Wang, Wei Wu, H. Long, Jia-Ni Huang, Zhongyu Wang, Tao Li, Shuk-Kuen Tang, Bo Zhu, De-Gao Chen

Biochemical and Biophysical Research Communications - BBRC

DOI

2019

Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation

Jie Zhou, Shuo Huang, Zhongyu Wang, Jia-Ni Huang, Liang Xu, Xuefeng Tang, Y. Wan, Qi-Jing Li, A. Symonds, H. Long, Bo Zhu

Nature Communications

DOI

2019

Poor glycemic control might compromise the efficacy of chemotherapy in non‐small cell lung cancer patients with diabetes mellitus

Xiang-Hua Zeng, Cheng Xu, Jia-Nan Cheng, Chengdu Sun, Zhongyu Wang, Z. Gong, H. Long, Bo Zhu

Cancer Medicine

DOI

2019

ERRα Regulates OTUB1 Expression to Promote Colorectal Cancer Cell Migration

Yi Zhou, Q. Jia, Xiaoqing Meng, Dian-gang Chen, Bo Zhu

Journal of Cancer

DOI

2019

Titin mutation associated with responsiveness to checkpoint blockades in solid tumors.

Q. Jia, Jun Wang, N. He, Ji He, Bo Zhu

JCI Insight

DOI

2019

The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection

Xiang-Yu Chen, Guoshuai Cao, Jialin Wu, Xinxin Wang, Z. Pan, Jianbao Gao, Qin Tian, Li-Fan Xu, Zhi-Rong Li, Ya-Xing Hao, Qi-Zhao Huang, Pengcheng Wang, Minglu Xiao, Luoyingzi Xie, Shupei Tang, Zhenyu Liu, Li Hu, Jian-Fang Tang, Ran He, Li Wang, Xin-Yuan Zhou, Yu-Zhang Wu, Mengjie Chen, Beicheng Sun, Bo Zhu, Jun Huang, L. Ye

Cellular & Molecular Immunology

DOI

2019

Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment

Yong-Sheng Li, Bo Zhu

Frontiers Research Topics

DOI

2018

年龄结构、产出效率和经济增长关系的理论与实证

朱波，侯亚楠

《统计与决策》，No. 4

下载原文

2018

Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location

Long-zhen Zhang, Yuetao Zhao, Ying Dai, Jia-Nan Cheng, Z. Gong, Yi Feng, Chengdu Sun, Q. Jia, Bo Zhu

Frontiers in Immunology

DOI

2018

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer

Q. Jia, Wei Wu, Yu-Qi Wang, Peter B. Alexander, Chengdu Sun, Z. Gong, Jia-Nan Cheng, Huaibo Sun, Y. Guan, X. Xia, Ling Yang, X. Yi, Y. Wan, Haidong Wang, Ji He, P. Futreal, Qi-Jing Li, Bo Zhu

Nature Communications

DOI

2018

Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages

H. Zha, Xinxin Wang, Ying Zhu, Dian-gang Chen, Xiao Han, Fei Yang, Jianbao Gao, Chunyan Hu, Chi Shu, Yi Feng, Yu-Long Tan, Jinyu Zhang, Yong-Sheng Li, Y. Wan, Bo Guo, Bo Zhu

Cancer immunology research

DOI

2018

Abstract 5739: Targeting EZH2 histone methyltransferase activity alleviates inflammatory bowel disease

H. Long, Jie Zhou, Zhongyu Wang, Shuo Huang, Bo Zhu

Immunology

DOI

2018

Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells

Lintao Zhao, Ran He, H. Long, Bo Guo, Q. Jia, Diyuan Qin, Si-Qi Liu, Zhongyu Wang, T. Xiang, Jue Zhang, Yu-Long Tan, Jia-Ni Huang, Jun-Ying Chen, Fang Wang, Minglu Xiao, Jianbao Gao, Xin-Xin Yang, Haotao Zeng, Xinxin Wang, Chunyan Hu, Peter B. Alexander, A. Symonds, Jia Yu, Y. Wan, Qi-Jing Li, L. Ye, Bo Zhu

Nature Medicine

DOI

2018

TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.

Chao Liu, Jing Luo, Yuetao Zhao, Zhongyu Wang, Jie Zhou, Shuo Huang, Jia-Ni Huang, H. Long, Bo Zhu

International Journal of Molecular Medicine

DOI

2018

Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19.

Yarong Liu, Bo Zhu, Q. Jia, H. Feng, Hong-Liang Fang, Jing Chen, Zi-Xiao Shi, J. Tao, B. Wei, Rong-Lin Xie, Qi-Jing Li, Pin Wang

DOI

2018

Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival

Xinxin Wang, Dian-gang Chen, Jianbao Gao, H. Long, H. Zha, Anmei Zhang, Chi Shu, Li Zhou, Fei Yang, Bo Zhu, Wei Wu

Cancer Management and Research

DOI

2018

Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer

Yi Feng, Ying Dai, Z. Gong, Jia-Nan Cheng, Long-zhen Zhang, Chengdu Sun, Xiang-Hua Zeng, Q. Jia, Bo Zhu

OncoTargets and Therapy

DOI

2018

Editorial: Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment

Yong-Sheng Li, Bo Zhu

Frontiers in Immunology

DOI

2018

Potent immunogenicity in BRCA1‐mutated patients with high‐grade serous ovarian carcinoma

Ying Dai, Chengdu Sun, Yi Feng, Q. Jia, Bo Zhu

Journal of Cellular and Molecular Medicine

DOI

2018

Remission observed from a phase 1 clinical study of CAR-T therapy with safety switch targeting BCMA for patients with relapsed/refractory multiple myeloma.

Yarong Liu, Zhi Chen, R. Wei, L. Shi, H. Feng, Zi-Xiao Shi, J. Tao, Rong-Lin Xie, B. Wei, Jing Chen, Hong-Liang Fang, Bo Zhu, Qi-Jing Li, Pin Wang

DOI

2018

Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19

Lina Liu, Lintao Zhao, Yang Yang, Jianbao Gao, Chunyan Hu, Bo Guo, Bo Zhu

Oncology Letters

DOI

2018

Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2

Ying Zhu, Jie Zhou, Yi Feng, Liying Chen, Long-zhen Zhang, Fei Yang, H. Zha, Xinxin Wang, Xiao Han, Chi Shu, Y. Wan, Qi-Jing Li, Bo Guo, Bo Zhu

Frontiers in Immunology

DOI

2018

Programmed death ligand 1 expression and CD8+ tumor-infiltrating lymphocyte density differences between paired primary and brain metastatic lesions in non-small cell lung cancer.

Jie Zhou, Z. Gong, Q. Jia, Yan Wu, Zhenzhou Yang, Bo Zhu

Biochemical and Biophysical Research Communications - BBRC

DOI

2018

In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia.

Zhi-Qiong Cheng, R. Wei, Qiuling Ma, Lin Shi, Feng He, Zi-Xiao Shi, Tao Jin, Rong-Lin Xie, B. Wei, Jing Chen, Hong-Liang Fang, Xiaolu Han, Jennifer A. Rohrs, P. Bryson, Yarong Liu, Qi-Jing Li, Bo Zhu, Pin Wang

Molecular Therapy

DOI

2017

S100B Mediates Stemness of Ovarian Cancer Stem‐Like Cells Through Inhibiting p53

Tao Yang, Jia-Nan Cheng, Yang Yang, Wei Qi, Yuetao Zhao, H. Long, R. Xie, Bo Zhu

Stem Cells

DOI

2017

Stroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung Cancer

Ying Zhu, Long-zhen Zhang, H. Zha, Fei Yang, Chunyan Hu, Lin Chen, Bo Guo, Bo Zhu

International Journal on Biological Sciences

DOI

2017

Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter

Dian-gang Chen, Bo Zhu, Sheng-Qing Lv, Hongfan Zhu, Jinliang Tang, Chang-Ling Huang, Qing-Rui Li, Pu Zhou, Dong-lin Wang, Guang-hui Li

Journal of experimental & clinical cancer research : CR

DOI

2017

Immune Cell Metabolism in Tumor Microenvironment.

Yong-Sheng Li, Y. Wan, Bo Zhu

Advances in Experimental Medicine and Biology

DOI

2017

Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy

Qi Zhang, Bo Zhu, Yong-Sheng Li

Frontiers in Immunology

DOI

2017

Disrupted fibroblastic reticular cells and interleukin-7 expression in tumor draining lymph nodes

Jianbao Gao, Lintao Zhao, Lina Liu, Yang Yang, Bo Guo, Bo Zhu

Oncology Letters

DOI

2017

Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade

H. Zha, Xiao Han, Ying Zhu, Fei Yang, Yong-Sheng Li, Qijing Li, Bo Guo, Bo Zhu

Oncoimmunology

DOI

2017

Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p.

Ying Zhu, Tao Li, Gang Chen, G. Yan, Xiaojing Zhang, Y. Wan, Qijing Li, Bo Zhu, Wen-Lei Zhuo

Lung Cancer

DOI

2017

Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells

Xiao Han, H. Zha, Fei Yang, Bo Guo, Bo Zhu

International Journal of Molecular Sciences

DOI

2017

CTCF promotes epithelial ovarian cancer metastasis by broadly controlling the expression of metastasis-associated genes

Lintao Zhao, Yang Yang, Shigang Yin, Tao Yang, Jing Luo, R. Xie, H. Long, Lubing Jiang, Bo Zhu

OncoTarget

DOI

2016

The tumor microenvironment disarms CD8+ T lymphocyte function via a miR-26a-EZH2 axis

H. Long, T. Xiang, Jing Luo, Fei Li, R. Lin, Siqi Liu, Shan Jiang, Chunyan Hu, Gang Chen, Elizabeth Wong, Y. Wan, Qi-Jing Li, Bo Zhu

Oncoimmunology

DOI

2016

Interleukin‐2 reverses CD8+ T cell exhaustion in clinical malignant pleural effusion of lung cancer

Chun-Yan Hu, Youyi Zhang, T. Wang, Lihua Chen, Z. Gong, Y. Wan, Qi-Jing Li, Yafei Li, Bo Zhu

Clinical and Experimental Immunology

DOI

2016

Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling.

Shuk-Kuen Tang, T. Xiang, Shuo Huang, Jie Zhou, Zhongyu Wang, R. Xie, H. Long, Bo Zhu

Cancer Letters

DOI

2016

Lipidome in colorectal cancer

Guifang Yan, Li-Qi Li, Bo Zhu, Yong-Sheng Li

OncoTarget

DOI

2016

MicroRNA-23a curbs necrosis during early T cell activation by enforcing intracellular reactive oxygen species equilibrium

Baojun Zhang, Si-Qi Liu, Chao-Ran Li, Erik A. Lykken, Shan Jiang, Elizabeth Wong, Z. Gong, Zhongfen Tao, Bo Zhu, Y. Wan, Qi-Jing Li

Immunity

DOI

2015

流动性约束、医疗支出与预防性储蓄——基于我国省际面板数据的实证研究

朱波，杭斌

《宏观经济研究》，No. 3

下载原文

2015

Temporal regulation of HIF-1 and NF-κB in hypoxic hepatocarcinoma cells

Yuan Jiang, Ying Zhu, Xinxin Wang, Juan Gong, Chunyan Hu, Bo Guo, Bo Zhu, Yong-Sheng Li

OncoTarget

DOI

2015

Quantitative assessment of the association between AXIN2 rs2240308 polymorphism and cancer risk

Juan Gong, Yuan Jiang, Ningbo Hao, Bo Zhu, Yong-Sheng Li

Scientific Reports

DOI

2015

CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition

H. Long, T. Xiang, Wei Qi, Jia-Ni Huang, Jun-Ying Chen, Lu-Hang He, Zhi-Qing Liang, Bo Guo, Yong-Sheng Li, R. Xie, Bo Zhu

OncoTarget

DOI

2015

EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB.

Kailong Lin, Jia-Nan Cheng, Tao Yang, Yong-Sheng Li, Bo Zhu

Biochemical and Biophysical Research Communications - BBRC

DOI

2015

T-cell exhaustion in the tumor microenvironment

Yan Jiang, Yu Li, Bo Zhu

Cell Death and Disease

DOI

2015

STIM1 Mediates Hypoxia-Driven Hepatocarcinogenesis via Interaction with HIF-1.

Yong-Sheng Li, Bo Guo, Qichao Xie, Du-Yun Ye, Dongxin Zhang, Ying Zhu, Hongxiang Chen, Bo Zhu

Cell Reports

DOI

2015

Essential role of TNF-alpha in development of spleen fibroblastic reticular cells.

Lintao Zhao, Jun-Ying Chen, Lina Liu, Jianbao Gao, Bo Guo, Bo Zhu

Cellular Immunology

DOI

2015

Targeting the Wnt‐Regulatory Protein CTNNBIP1 by microRNA‐214 Enhances the Stemness and Self‐Renewal of Cancer Stem‐Like Cells in Lung Adenocarcinomas

Wei Qi, Jun-Ying Chen, Xiaoming Cheng, Jia-Ni Huang, T. Xiang, Qijing Li, H. Long, Bo Zhu

Stem Cells

DOI

2015

Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy

Jianbao Gao, Lintao Zhao, Y. Wan, Bo Zhu

International Journal of Molecular Sciences

DOI

2015

miR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment

R. Lin, J. Sampson, Qi-Jing Li, Bo Zhu

Oncoimmunology

DOI

2015

microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu)

H. Long, Zhongyu Wang, Jun-Ying Chen, T. Xiang, Qijing Li, Xinwei Diao, Bo Zhu

OncoTarget

DOI

2015

Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway.

T. Xiang, L. Du, Petra Pham, Bo Zhu, Shi-Bo Jiang

Cancer Letters

DOI

2014

养老保险对居民消费影响的实证分析

朱波，杭斌

《统计与决策》，No. 24

下载原文

2014

MeCP2 enforces Foxp3 expression to promote regulatory T cells’ resilience to inflammation

Chao-Ran Li, Shan Jiang, Si-Qi Liu, Erik A. Lykken, Lintao Zhao, J. Sevilla, Bo Zhu, Qi-Jing Li

Proceedings of the National Academy of Sciences of the United States of America

DOI

2014

T lymphocytes maintain structure and function of fibroblastic reticular cells via lymphotoxin (LT)-B

Lintao Zhao, Lina Liu, Jianbao Gao, Yang Yang, Chunyan Hu, Bo Guo, Bo Zhu

BMC Immunology

DOI

2014

Tissue factor in tumor microenvironment: a systematic review

Xiao Han, Bo Guo, Yong-Sheng Li, Bo Zhu

Journal of Hematology & Oncology

DOI

2014

Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.

R. Lin, Ling Chen, Gang Chen, Chunyan Hu, Shan Jiang, J. Sevilla, Y. Wan, J. Sampson, Bo Zhu, Qi-Jing Li

Journal of Clinical Investigation

DOI

2013

Dynamic optimal capital growth with risk constraints

Luo Yong, Zhu Bo, Tang Yong

Economic Modelling，Vol. 30

DOI

2013

中国逆周期缓冲资本调整指标研究——基于金融体系脆弱时期的实证分析

朱波，卢露

《国际金融研究》，No. 10

下载原文

2013

Targeting miR-23a in CD8+ cytotoxic T lymphocytes for tumor immunotherapy (P2072)

R. Lin, Ling Chen, Chunyan Hu, Gang Chen, Shan Jiang, J. Sevilla, Y. Wan, Bo Zhu, Qi-Jing Li

Journal of Immunology

DOI

2013

Dynamically expressed microRNA-15b modulates the activities of CD8+ T lymphocytes in mice with Lewis lung carcinoma

G. Zhong, Xiaoming Cheng, H. Long, Lu-Hang He, Wei Qi, T. Xiang, Zhong-Quan Zhao, Bo Zhu

Journal of Translational Medicine

DOI

2013

Tumor environment interferes with the priming of the anti-infection CD8~+T cell immune response in mice

Bo Zhu

2012

中国地方政府制度创新现状分析与趋势预测——基于文献统计与实践案例的分析

庄乾，朱波

《攀登》

2012

地方政府制度创新现状分析与趋势预测——基于文献统计与实践案例的分析

庄乾，朱波

《党政干部学刊》

2012

Aberrant microRNAs expression in CD133+/CD326+ human lung adenocarcinoma initiating cells from A549

Sheng Lin, Jian-Guo Sun, Jingyang Wu, H. Long, Conghui Zhu, T. Xiang, Hu Ma, Zhong-Quan Zhao, Q. Yao, An-Mei Zhang, Bo Zhu, Zheng-Tang Chen

Molecules and Cells

DOI

2012

Progress in regulating mechanism of miR in T cell's immune function

Bo Zhu

2011

构建和谐社会的行政障碍研究——以公共行政学的视角审视

庄乾，朱波，张小敏

《安徽乡村振兴研究》

2011

[Isolation and identification of cancer stem cells from primary human ovarian cancer tissues].

Sheng Lin, H. Long, T. Xiang, Bo Zhu, R. Xie

Zhonghua zhong liu za zhi [Chinese journal of oncology]

DOI

2010

Cancer stem cell and tumor immunity

Bo Zhu

2009

需求价格弹性及非对称效应下的价格决策

朱波

《中国物价》，No. 3

下载原文

2008

公民政策参与视角下的公共政策合法化问题初探

朱波

《理论观察》

2007

金融发展与经济增长实证研究述评

朱波

《商业研究》，No. 4

下载原文DOI

2007

坚定不移地发展社会主义民主政治

朱波

《新东方》

2005

金融危机理论与模型的最新发展及对我国的启示

朱波，赵锦辉

《中国社会科学院大学学报》，No. 3

下载原文

此主页由公开资料整理，尚未经学者本人认领。